KNSA logo

KNSA Return On Equity

Annual ROE:

-9.85%-13.22%(-392.28%)
December 31, 2024

Summary

  • As of today, KNSA annual return on equity is -9.85%, with the most recent change of -13.22% (-392.28%) on December 31, 2024.
  • During the last 3 years, KNSA annual ROE has risen by +53.70% (+84.50%).
  • KNSA annual ROE is now -115.61% below its all-time high of 63.10%, reached on December 31, 2022.

Performance

KNSA ROE Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherKNSAprofitability metrics

Quarterly ROE:

1.06%+4.91%(+127.53%)
June 30, 2025

Summary

  • As of today, KNSA quarterly return on equity is 1.06%, with the most recent change of +4.91% (+127.53%) on June 30, 2025.
  • Over the past year, KNSA quarterly ROE has increased by +3.47% (+143.98%).
  • KNSA quarterly ROE is now -98.51% below its all-time high of 71.35%, reached on December 31, 2022.

Performance

KNSA Quarterly ROE Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherKNSAprofitability metrics

ROE Formula

ROE =  Net Income
Shareholders Equity
✕ 100%

KNSA ROE Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1Y1 Year-392.3%+144.0%
3Y3 Years+84.5%+101.8%
5Y5 Years+84.7%+102.1%

KNSA ROE Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs Low
3Y3-Year-115.6%+84.5%-98.5%+110.7%
5Y5-Year-115.6%+84.7%-98.5%+101.6%
All-TimeAll-Time-115.6%+93.6%-98.5%+100.5%

KNSA ROE History

DateAnnualQuarterly
Jun 2025
-
1.06%(+127.5%)
Mar 2025
-
-3.85%(+61.1%)
Dec 2024
-9.85%(-392.3%)
-9.90%(-369.2%)
Sep 2024
-
-2.11%(+12.4%)
Jun 2024
-
-2.41%(-215.9%)
Mar 2024
-
2.08%(-39.7%)
Dec 2023
3.37%(-94.7%)
3.45%(+305.4%)
Sep 2023
-
-1.68%(-102.5%)
Jun 2023
-
66.63%(+1.2%)
Mar 2023
-
65.87%(-7.7%)
Dec 2022
63.10%(+199.3%)
71.35%(+10.4%)
Sep 2022
-
64.64%(+210.1%)
Jun 2022
-
-58.70%(+5.9%)
Mar 2022
-
-62.35%(+3.9%)
Dec 2021
-63.55%
-64.86%(-3.0%)
Sep 2021
-
-62.99%(+4.6%)
DateAnnualQuarterly
Jun 2021
-
-66.05%(-0.1%)
Mar 2021
-
-66.00%(-10.6%)
Dec 2020
-60.06%(+6.4%)
-59.68%(-10.5%)
Sep 2020
-
-53.99%(-6.3%)
Jun 2020
-
-50.77%(-4.9%)
Mar 2020
-
-48.41%(+19.9%)
Dec 2019
-64.15%(+3.9%)
-60.47%(-0.3%)
Sep 2019
-
-60.29%(-7.9%)
Jun 2019
-
-55.86%(-6.0%)
Mar 2019
-
-52.71%(-20.0%)
Dec 2018
-66.74%(+56.7%)
-43.91%(-5.4%)
Sep 2018
-
-41.66%(+5.6%)
Jun 2018
-
-44.15%(+31.5%)
Mar 2018
-
-64.46%(+70.1%)
Dec 2017
-154.04%(-248.0%)
-215.80%
Dec 2016
-44.26%
-

FAQ

  • What is Kiniksa Pharmaceuticals International, plc annual return on equity?
  • What is the all-time high annual ROE for Kiniksa Pharmaceuticals International, plc?
  • What is Kiniksa Pharmaceuticals International, plc annual ROE year-on-year change?
  • What is Kiniksa Pharmaceuticals International, plc quarterly return on equity?
  • What is the all-time high quarterly ROE for Kiniksa Pharmaceuticals International, plc?
  • What is Kiniksa Pharmaceuticals International, plc quarterly ROE year-on-year change?

What is Kiniksa Pharmaceuticals International, plc annual return on equity?

The current annual ROE of KNSA is -9.85%

What is the all-time high annual ROE for Kiniksa Pharmaceuticals International, plc?

Kiniksa Pharmaceuticals International, plc all-time high annual return on equity is 63.10%

What is Kiniksa Pharmaceuticals International, plc annual ROE year-on-year change?

Over the past year, KNSA annual return on equity has changed by -13.22% (-392.28%)

What is Kiniksa Pharmaceuticals International, plc quarterly return on equity?

The current quarterly ROE of KNSA is 1.06%

What is the all-time high quarterly ROE for Kiniksa Pharmaceuticals International, plc?

Kiniksa Pharmaceuticals International, plc all-time high quarterly return on equity is 71.35%

What is Kiniksa Pharmaceuticals International, plc quarterly ROE year-on-year change?

Over the past year, KNSA quarterly return on equity has changed by +3.47% (+143.98%)
On this page